$8.11
Currently 17 wall-street analysts regularly analyze the financials of Neogenomics, Inc. on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Neogenomics, Inc. (NEO) have a share price target of $10. This median of share price forecast represents a 23.3% upside from the latest price of $8.11 as on 18.09.25.
As per the chart shown above, analysts believe that the Neogenomics, Inc. (NEO) share price will touch around $10 in next 12-months.
Below is a chart showing the percentage difference between Neogenomics, Inc.'s share price and its median forecast price. As on 18.09.25, the difference is -47.23%
Based on 17 analysts tracking and researching Neogenomics, Inc. (NEO) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 8 | 8 | 8 |
Outperform | 5 | 5 | 5 |
Hold | 4 | 4 | 4 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |